Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Navidea Biopharmaceuticals, Inc. (NAVB : AMEX)
 
 • Company Description   
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio.

Number of Employees: 15

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.77 Daily Weekly Monthly
20 Day Moving Average: 1,071,453 shares
Shares Outstanding: 30.30 (millions)
Market Capitalization: $23.29 (millions)
Beta: 1.38
52 Week High: $2.19
52 Week Low: $0.72
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -10.60% -2.41%
12 Week -10.60% -3.38%
Year To Date -23.12% -8.94%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
4995 BRADENTON AVENUE SUITE 240
-
DUBLIN,OH 43017
USA
ph: 614-793-7500
fax: 614-793-7522
jkaufman@navidea.com http://www.navidea.com
 
 • General Corporate Information   
Officers
Alexander L. Cappello - Chairman of the Board of Directors
John K. Scott - Vice Chairman of the Board of Directors
Michael S. Rosol - Chief Medical Officer
Erika L. Eves - Vice President; Finance & Administration
Amit Bhalla - Director

Peer Information
Navidea Biopharmaceuticals, Inc. (ABMD)
Navidea Biopharmaceuticals, Inc. (DMDS)
Navidea Biopharmaceuticals, Inc. (CPWY.)
Navidea Biopharmaceuticals, Inc. (EQUR)
Navidea Biopharmaceuticals, Inc. (ECIA)
Navidea Biopharmaceuticals, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 63937X202
SIC: 2835
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/10/22
Share - Related Items
Shares Outstanding: 30.30
Most Recent Split Date: 4.00 (0.05:1)
Beta: 1.38
Market Capitalization: $23.29 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/10/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 37.13
Price/Cash Flow: -
Price / Sales: 43.87
EPS Growth
vs. Year Ago Period: 9.09%
vs. Previous Quarter: 16.67%
Sales Growth
vs. Year Ago Period: -77.17%
vs. Previous Quarter: -47.92%
ROE
03/31/22 - -314.90
12/31/21 - -182.20
09/30/21 - -116.36
ROA
03/31/22 - -131.12
12/31/21 - -126.95
09/30/21 - -114.53
Current Ratio
03/31/22 - -
12/31/21 - 1.02
09/30/21 - 1.87
Quick Ratio
03/31/22 - -
12/31/21 - 0.99
09/30/21 - 1.83
Operating Margin
03/31/22 - -
12/31/21 - -2,209.23
09/30/21 - -1,557.43
Net Margin
03/31/22 - -
12/31/21 - -2,209.23
09/30/21 - -1,557.43
Pre-Tax Margin
03/31/22 - -
12/31/21 - -2,202.07
09/30/21 - -1,555.14
Book Value
03/31/22 - -
12/31/21 - 0.02
09/30/21 - 0.14
Inventory Turnover
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©